CINACALCET Drug Patent Profile
✉ Email this page to a colleague
When do Cinacalcet patents expire, and when can generic versions of Cinacalcet launch?
Cinacalcet is a drug marketed by Accord Hlthcare, Alkem Labs Ltd, Aurobindo Pharma Ltd, Chartwell Rx, Cipla, Dr Reddys, Hetero Labs Ltd V, Lupin, Piramal, Rising, Stevens J, Strides Pharma, Sun Pharm, and Watson Labs Teva. and is included in fourteen NDAs.
The generic ingredient in CINACALCET is cinacalcet hydrochloride. There are twenty-four drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cinacalcet hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cinacalcet
A generic version of CINACALCET was approved as cinacalcet hydrochloride by AUROBINDO PHARMA LTD on March 8th, 2018.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CINACALCET?
- What are the global sales for CINACALCET?
- What is Average Wholesale Price for CINACALCET?
Summary for CINACALCET
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 14 |
| Drug Prices: | Drug price information for CINACALCET |
| DailyMed Link: | CINACALCET at DailyMed |
US Patents and Regulatory Information for CINACALCET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Teva | CINACALCET HYDROCHLORIDE | cinacalcet hydrochloride | TABLET;ORAL | 204377-002 | Dec 27, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Stevens J | CINACALCET HYDROCHLORIDE | cinacalcet hydrochloride | TABLET;ORAL | 204364-002 | Dec 2, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | CINACALCET HYDROCHLORIDE | cinacalcet hydrochloride | TABLET;ORAL | 203422-001 | Oct 16, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
